Ligand Pharmaceuticals Launches Pelthos Therapeutics and Appoints Scott Plesha As Chief Executive Officer

Apr 03, 2024•over 1 year ago

Company

Ligand Pharmaceuticals Incorporated

San DiegoBiopharmaPharmaceuticalBiotechnologyHealth Care

Description

Ligand Pharmaceuticals announced the launch of Pelthos Therapeutics, a biopharmaceutical company, and the appointment of Scott Plesha as Chief Executive Officer. Scott Plesha brings more than 30 years of experience in the pharmaceutical industry, including two decades building and leading specialty pharmaceutical commercial organizations.

Company Information

Company

Ligand Pharmaceuticals Incorporated

Location

San Diego, California, United States

About

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Their business model seeks to generate value for stockholders by creating a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Ligand Pharmaceuticals Launches Pelthos Therapeutics and Appoints Scott Plesha As Chief Executive Officer

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Executive Insights

Company Information